T cell receptor VB repertoire diversity in patients with immune thrombocytopenia following splenectomy

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Clinical and Experimental Immunology

• Publication date

  2003-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1365-2249.2003.02239.xPMID 12930375PMCID PMC1808786
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Suppression of autoreactive T-cell response to glycoprotein IIb/IIIa by blockade of CD40/CD154 interaction: implications for treatment of immune thrombocytopenic purpura.

  2003cited by this paper
• Long term follow‐up after splenectomy performed for immune thrombocytopenic purpura (ITP)

  2003cited by this paper
• Immunodominant epitopes on glycoprotein IIb-IIIa recognized by autoreactive T cells in patients with immune thrombocytopenic purpura.

  2001cited by this paper
• Abnormal T-cell repertoire is consistent with immune process underlying the pathogenesis of paroxysmal nocturnal hemoglobinuria.

  2000cited by this paper
• Overview of idiopathic thrombocytopenic purpura: new approach to refractory patients.

  2000cited by this paper
• Long‐term decrease of CD4+CD45RA+ T cells and impaired primary immune response after post‐traumatic splenectomy

  1999cited by this paper
• The response to high‐dose intravenous immunoglobulin or steroids is not predictive of outcome after splenectomy in adults with autoimmune thrombocytopenic purpura

  1999cited by this paper
• Characterization of T-cell repertoire of the bone marrow in immune-mediated aplastic anemia: evidence for the involvement of antigen-driven T-cell response in cyclosporine-dependent aplastic anemia.

  1999cited by this paper
• Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody.

  1998cited by this paper
• T‐Cell Clonal Expansion in Patients with B‐Cell Lymphoproliferative Disorders

  1998cited by this paper
• Spread of clonal T-cell expansions in rheumatoid arthritis patients.

  1996cited by this paper
• Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity.

  1996cited by this paper
• Oligoclonal accumulation of T cells in peripheral blood from patients with idiopathic thrombocytopenic purpura

  1996cited by this paper
• Platelet autoantibodies (IgG, IgM, IgA) against glycoproteins IIb/IIIa and Ib/IX in patients with thrombocytopenia

  1996cited by this paper
• Expansion of a recurrent V beta 5.3+ T-cell population in newly diagnosed and untreated HLA-DR2 multiple sclerosis patients.

  1996cited by this paper
• Mitogens, superantigens, and nominal antigens elicit distinctive patterns of TCRB CDR3 diversity.

  1996cited by this paper
• T-cell repertoires in healthy and diseased human tissues analysed by T-cell receptor beta-chain CDR3 size determination: evidence for oligoclonal expansions in tumours and inflammatory diseases.

  1995cited by this paper
• CDR3 sequence motifs shared by oligoclonal rheumatoid arthritis synovial T cells. Evidence for an antigen-driven response.

  1994cited by this paper
• Spectrum of Ig classes, specificities, and titers of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpura.

  1994cited by this paper
• Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. Correlation with immune status.

  1994cited by this paper
• Dominant clonotypes in the repertoire of peripheral CD4+ T cells in rheumatoid arthritis.

  1994cited by this paper
• Elevated numbers of gamma-delta (γδ+) T lymphocytes in children with immune thrombocytopenic purpura

  1994cited by this paper
• Clonotype analysis of peripheral blood T cells and autoantigen-reactive T cells from patients with mixed connective tissue disease.

  1994cited by this paper
• Elevated numbers of gamma-delta (gamma delta+) T lymphocytes in children with immune thrombocytopenic purpura.

  1994cited by this paper
• Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis.

  1993cited by this paper
• Autoantibodies against platelet glycoproteins in autoimmune thrombocytopenic purpura: their clinical significance and response to treatment.

  1993cited by this paper
• Phenotypic and clonal analysis of T lymphocytes in childhood immune thrombocytopenic purpura.

  1993cited by this paper
• Selection for T-cell receptor Vβ–Dβ–Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis

  1993cited by this paper
• Accumulation of multiple T cell clonotypes in the synovial lesions of patients with rheumatoid arthritis revealed by a novel clonality analysis.

  1992cited by this paper
• Molecular and biological characterization of a murine ligand for CD40

  1992cited by this paper
• Molecular and biological characterization of a murine ligand for CD40.

  1992cited by this paper
• T cell receptor and alloimmune thrombocytopenias: a model for autoimmune diseases?

  1992cited by this paper
• Increased antiplatelet T helper lymphocyte reactivity in patients with autoimmune thrombocytopenia.

  1991cited by this paper
• Platelet destruction in autoimmune thrombocytopenic purpura: kinetics and clearance of indium-111-labeled autologous platelets.

  1989cited by this paper
• T cell antigen receptors in autoimmunity.

  1988cited by this paper
• Quantitation of platelet-binding IgG produced in vitro by spleens from patients with idiopathic thrombocytopenic purpura.

  1974cited by this paper
• Detection of Splenic Anti‐Platelet Antibody Synthesis in Idiopathic Autoimmune Thrombocytopenic Purpura (ATP)

  1972cited by this paper

• Efficacy and safety of eltrombopag in combination with cyclosporine A for the treatment of adult refractory primary immune thrombocytopenia: a phase II, multicenter, single-arm, prospective study

  2026cites this paper
• Immune thrombocytopenia in adolescents and young adults

  2025cites this paper
• Desialylation and Apoptosis in Immune Thrombocytopenia: Implications for Pathogenesis and Treatment

  2024cites this paper
• How we treat primary immune thrombocytopenia in adults

  2023cites this paper
• Pathogenesis of refractory ITP: Overview

  2023cites this paper
• Chronic refractory immune thrombocytopenia in adolescents and young adults

  2023cites this paper
• Blood transcriptome and clonal T-cell correlates of response and non-response to eltrombopag therapy in a cohort of patients with chronic immune thrombocytopenia

  2020cites this paper
• Possible involvement of regulatory T cell abnormalities and variational usage of TCR repertoire in children with autoimmune neutropenia

  2020cites this paper
• [Management of multirefractory immune thrombocytopenia].

  2020cites this paper
• Identifying and Treating Refractory ITP: Difficulty in Diagnosis and Role of Combination Treatment.

  2019cites this paper
• Epidemiological perspective of chronic immune thrombocytopenia

  2019cites this paper
• The spleen in immune thrombocytopenia

  2018cites this paper
• ÉTUDE DES CELLULES LYMPHOÏDES INNÉES SPLÉNIQUES HUMAINES ET DE LEURS IMPLICATIONS AU COURS DE LA THROMBOPÉNIE IMMUNOLOGIQUE

  2018cites this paper
• Thrombopoietin receptor agonists in patients with persistent or chronic immune thrombocytopenia

  2018cites this paper
• Pathogenesis of immune thrombocytopenia.

  2017cites this paper
• Estudio de los factores involucrados en las manifestaciones hemorrágicas de la trombocitopenia inmune

  2015cites this paper
• Advances in immunopathogenesis of adult immune thrombocytopenia

  2013cites this paper
• immune thrombocytopenic purpura: a systematic review Effects of eradication of Helicobacter pylori infection in patients with

  2013cites this paper
• Defective regulatory B-cell compartment in patients with immune thrombocytopenia.

  2012cites this paper
• Immune Thrombocytopenia: Pathophysiologic and Clinical Update

  2012cites this paper
• Thrombopoietic growth factors in the treatment of immune thrombocytopenic purpura.

  2011cites this paper
• Pathophysiology and therapeutic options in primary immune thrombocytopenia.

  2011cites this paper
• ITP: a historical perspective

  2011cites this paper
• The feature of clonal expansion of TCR Vβ repertoire, thymic recent output function and TCRζ chain expression in patients with immune thrombocytopenic purpura

  2009cites this paper
• The feature of TRGV and TRDV repertoire distribution and clonality in patients with immune thrombocytopenic purpura

  2009cites this paper
• The ITP syndrome: pathogenic and clinical diversity.

  2009cites this paper
• Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review.

  2009cites this paper
• Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab.

  2008cites this paper
• Immune thrombocytopenic purpura.

  2007cites this paper
• Hemostasis, Thrombosis, and Vascular Biology

  2007cites this paper
• Idiopathic thrombocytopenic purpura: Current concepts in pathophysiology and management

  2007cites this paper